CN110743035A - Preparation method and application of intelligent antibacterial hydrogel - Google Patents

Preparation method and application of intelligent antibacterial hydrogel Download PDF

Info

Publication number
CN110743035A
CN110743035A CN201911074386.XA CN201911074386A CN110743035A CN 110743035 A CN110743035 A CN 110743035A CN 201911074386 A CN201911074386 A CN 201911074386A CN 110743035 A CN110743035 A CN 110743035A
Authority
CN
China
Prior art keywords
solution
hydrogel
antibacterial
bacteria
mouse
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201911074386.XA
Other languages
Chinese (zh)
Inventor
刘海波
周倩
王静
李青云
刘幽燕
廖丹葵
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangxi University
Original Assignee
Guangxi University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangxi University filed Critical Guangxi University
Priority to CN201911074386.XA priority Critical patent/CN110743035A/en
Publication of CN110743035A publication Critical patent/CN110743035A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/0066Medicaments; Biocides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/008Hydrogels or hydrocolloids
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/02Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075Macromolecular gels
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6402Atomic fluorescence; Laser induced fluorescence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62Encapsulated active agents, e.g. emulsified droplets
    • A61L2300/626Liposomes, micelles, vesicles
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2334/00O-linked chromogens for determinations of hydrolase enzymes, e.g. glycosidases, phosphatases, esterases
    • C12Q2334/20Coumarin derivatives
    • C12Q2334/224-Methylumbelliferyl, i.e. beta-methylumbelliferone, 4MU

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials For Medical Uses (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses a preparation method and application of intelligent antibacterial hydrogel. This method is achieved by using vesicles loaded with self-extinguishing fluorescent dyes. The vesicle is sensitive to a cell virulence factor generated by the thallus and used for regulating the density of a key population, and the generated thallus toxin can cause the vesicle to break under the condition that a wound is infected by bacteria, so that the dye is released from the vesicle and emits strong fluorescence. Therefore, whether the wound is infected or not can be judged according to the fluorescence intensity, and the risk of infection is further reduced. In addition, synchronous intelligent response to pathogen detection and sterilization can be realized by loading a photosensitive antibacterial agent in the vesicle. Compared with the traditional pathogenic bacteria detection method, the method has the characteristics of simple preparation process, convenient operation, high efficiency, rapidness, accuracy and the like.

Description

Preparation method and application of intelligent antibacterial hydrogel
Technical Field
The invention belongs to the technical field of biosensing, and particularly relates to a preparation method and application of an intelligent antibacterial hydrogel.
Background
With the wide clinical application of antibiotic drugs, the problem of drug resistance of bacteria is getting worse, the drug resistance is getting worse, the separation rate of clinical multi-drug resistant strains is quite high, the drug resistance mechanism is complex and changeable, and great challenges are brought to clinical treatment. At present, the detection of pathogenic microorganisms and the drug resistance thereof are mainly completed by analysis means such as bacterial culture, biochemical identification, polymerase chain reaction amplification, real-time fluorescence quantitative gene amplification technology, enzyme-linked immunosorbent assay, chip technology and the like. The detection means has the problems of long detection period, high cost, complex operation and the like, and is difficult to meet the requirement of clinical real-time detection. Therefore, the development of a rapid and sensitive detection method has important practical significance for the prevention and control of pathogenic microorganisms and the like.
A wound dressing is a material that is applied to a skin wound to promote wound healing. The hydrogel dressing is a novel dressing invented in recent years, and is widely researched and applied in the field of medical dressings. There are studies on the drug release and antibacterial effects of PEO/PVA graft copolymer hydrogels prepared by irradiating a mixture of polyethylene oxide and polyvinyl alcohol with electron beams and incorporating gentamicin. Currently, antibacterial agents loaded on hydrogel finished products mainly comprise nano silver, sulfapyridine salt, curcumin and tetracycline drugs. Wherein the market share of the nano-silver antibacterial hydrogel is more than 60%. Research shows that the nano silver has great toxicity and is not suitable for wound surfaces. Therefore, antibiotic antibacterial agents are widely used, the hydrogel can achieve the purpose of resisting infection by releasing antibiotics and directly killing or inhibiting the growth of bacteria by interfering the important life process of the bacteria with the antibiotics, but the bacteria have fast adaptability and evolutionary capability, and are extremely easy to generate negative effects such as drug resistance, microbial flora imbalance and the like. There is therefore a need for an effective and less drug resistant alternative or adjunct to antibiotic therapy. Photodynamic antibacterial therapy (PACT) is one of the most promising therapies that have emerged in recent years. The PACT principle of antibacterial action is that photosensitizer selectively gathers on bacterial cell wall and cell membrane, under the excitation of appropriate wavelength light source, relies on the participation of oxygen, through active oxygen substances such as I type, II type reaction production singlet oxygen, directly breaks bacterial cell wall and membrane system, influences its metabolism, and then leads to the bacterium death. The PACT antibacterial effect can effectively kill pathogenic bacteria and inactivate bacterial toxin factors, and has the unique advantage of effectively killing pathogenic bacteria and not easily generating tolerance.
Based on the above problems, we have devised a hydrogel dressing having the ability to detect bacterial microorganisms and kill bacteria intelligently, in which intelligent detection of pathogenic bacteria is achieved by using vesicles loaded with self-extinguishing fluorescent dyes, and in addition, synchronous intelligent response to pathogenic bacteria detection and killing can be achieved by loading photosensitive antibacterial agents in the vesicles.
Disclosure of Invention
The invention aims to provide a preparation method and application of an intelligent antibacterial hydrogel.
The technical scheme for solving the technical problems is as follows:
1. a preparation method of intelligent antibacterial hydrogel comprises the following operation steps:
1) 73.4mg of phospholipid 1, 2-dipalmitoyl-Sn-glycero-3-phosphocholine (DPPC), 38.6mg of cholesterol and 34.6mg of 10, 12-tricosane-dienoic acid (TCDA) were weighed out and dissolved in 1mL of chloroform at a concentration of 100mmol/dm3. 660. mu.L of DPPC, 240. mu.L of cholesterol and 300. mu.L of TCDA were mixed in a nitrogen stream and then dried, freed of impurities and dehydrated.
2) Will contain 50mmol/dm310mL buffer and lipid of fluorescent agentMixing, freezing, extruding the lipid mixture through polycarbonate membrane with vesicle extruder, and storing the vesicle at 4 deg.C.
3) The size of the product is 90X 1mm3The hydrogel dressing is characterized in that 4-methyl umbelliferyl- α -D-Mannoside (MUD) is grafted on the hydrogel, an enzyme released by pathogenic bacteria can cut MUD fluorescent agent, a fluorophore 4-methyl umbelliferone (4-MU) is released into the hydrogel, and blue light is shown under an ultraviolet lamp (lambda & gt 365 nm).
4) The filling materials in the sac are the sac body, a pathogen detection fluorescent agent and chitosan, the fluorescent agent not only can detect pathogens, but also can play a role in sterilization under the condition of natural illumination, and the main antibacterial photosensitizer is natural photosensitive antibacterial agents such as hypericin and the like.
2. The application of the intelligent antibacterial hydrogel comprises the following steps: the method is applied to detection of pathogenic bacteria, intelligent antibacterial experiments and influence of an intelligent photosensitive antibacterial agent on wound healing of mice.
Due to the adoption of the technical scheme, the preparation method of the intelligent adhesive bandage dressing with the detection and antibacterial effects has the beneficial technical effects that:
1. the raw material for preparing the antibacterial hydrogel dressing mainly comprises chitosan. The structure and properties of chitosan are similar to those of extracellular matrix; the biocompatibility is good, and the rejection reaction with human tissues is avoided; the chitosan has good biological activity, has the effects of inhibiting bacteria, reducing cholesterol and the like, and can also promote the growth of epithelial cells; the chitosan can be degraded in the presence of lysozyme, the degradation process is mild and safe, and the degradation product is glucosamine which can directly enter a metabolic pathway.
2. The vesicle filler mainly comprises the vesicle, the pathogen detection fluorescent agent and chitosan, the fluorescent agent in the vesicle is mainly a natural extract, the fluorescent agent not only can detect the pathogen but also can play a role in sterilization under natural light, and the detection and treatment of the pathogenic bacteria of the wound are synchronously realized.
3. The reagents used in the preparation of the invention have no toxic or side effect, and the prepared hydrogel dressing has good biocompatibility.
Drawings
FIG. 1 is a graph showing the effect of enzymatic reactions in solution.
A, B, C are Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus, respectively.
FIG. 2 is a graph showing the effect of enzymatic reactions on a hydrogel dressing.
A, B, C are Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus, respectively.
Fig. 3 is a graph of the effect of the intelligent hydrogel wound dressing on detection of pathogens under an ultraviolet lamp.
In the figure, the left figure is a figure when not applied; the right image is the effect image after application.
FIG. 4 is a graph showing the antibacterial effect of hypericin.
In the figure, A, B, C, D photodynamic therapy group, photosensitizer only group, xenon lamp only irradiated group and blank control group.
FIG. 5 is a comparative graph of epidermal histology of mice in the experimental group and the control group of the animal of the present invention.
In the figure, A, B, C represents a normal mouse, an illuminated group and an unlit group.
Detailed description of the preferred embodiments
The present invention will be described in further detail with reference to examples. The following are examples of the present invention, and are not intended to limit the present invention, and any modifications, substitutions, improvements, etc. made on the basis of the present invention are included in the scope of the present invention.
Example 1 Intelligent antimicrobial hydrogel
The application of the intelligent antibacterial hydrogel in the detection of pathogenic bacteria comprises the following operation steps:
1. enzymatic reaction in solution
For the enzymatic reaction in the solution, 50. mu.L of MUD solution was added to a 96-well plate containing 50. mu.L of the bacterial solution, the 96-well plate was sealed with a sealing tape, and the plate was placed in a fluorescence cell to observe the fluorescence intensity as shown in FIG. 1.
2. Enzymatic reaction of hydrogel dressing on culture dish
50 mu L of MUD solution is grafted on the surface of the prepared hydrogel dressing, then the hydrogel dressing is placed on a culture dish coated with 50 mu L of bacterial liquid, and the luminous intensity of the hydrogel dressing is observed as shown in figure 2.
3. Preparation of hypericin clathrate
Adding β -CD (β -cyclodextrin) 5.0g into 30 ml of NaOH solution 30%, stirring at room temperature to dissolve β -CD, adding EP 2.41ml into the mixed solution at 30 ℃, stirring for 24h, cooling to room temperature, desalting by a dialysis method, evaporating the solution in a dialysis bag to be viscous, adding absolute ethyl alcohol, precipitating white solid, filtering the white solid, carrying out vacuum freeze drying to obtain β -CDP (β -cyclodextrin polymer), dissolving β -CDP 80mg and Hyp (hypericin) 10mg in a proper amount of water, fully stirring for at least 24h at room temperature, filtering the mixed solution after the reaction is finished, removing the residual Hyp to obtain a dark purple solution containing an inclusion complex, and carrying out vacuum freeze drying to obtain a dark purple product Hyp- β -CDP (hypericin inclusion complex).
4. Hypericin clathrate is filled into vesicle
Uniformly preparing a plurality of round holes in the hydrogel, adding vesicles and chitosan into the holes, wherein the fillers in the vesicles are hypericin clathrate or other natural photosensitive antibacterial agents.
Results of the experiment
A, B, C in the figure 1 is enzymatic reaction of pseudomonas aeruginosa, escherichia coli and staphylococcus aureus in a 96-well plate respectively, the enzymatic reaction lasts for 1h, and the fluorescent substrate MUD can fluoresce the three bacteria according to the judgment of the fluorescence intensity, which indicates that the fluorescent substrate MUD has a certain detection effect on the three bacteria; in FIG. 2, A, B, C culture dishes are respectively provided with Pseudomonas aeruginosa, Escherichia coli and Staphylococcus aureus, the hydrogel dressing is cut into a square with the size of 1.5cm multiplied by 1.5cm, a fluorescent substrate is grafted on the hydrogel dressing, the dressing is placed on the culture dish, an enzymatic reaction is carried out for 1h, and the dressing has a detection effect on the three bacteria from the fluorescence intensity in the drawing; fig. 3 is a comparison of before and after the auxiliary materials are activated under an ultraviolet lamp, and it can be seen from the figure that the vesicles are cleaved by toxins released by pathogenic bacteria, hypericin is released, and red fluorescence is exhibited under the ultraviolet lamp (λ 365 nm).
Example 2
The application of the intelligent antibacterial hydrogel in an intelligent antibacterial experiment comprises the following operation steps:
1. bacterial culture
The bacteria were picked from the LB plate and placed in a 50ml centrifuge tube, 10ml of LB medium was added to the centrifuge tube, and the tube was incubated for 15 hours at 37 ℃ on a shaker.
2. Preparation of solid Medium
Taking a 1000ml beaker, adding 500ml of distilled water, weighing 5g of beef extract, 10g of peptone, 5g of agar and 5g of sodium chloride, dissolving in water, adjusting the pH to about 7.2 by using a 10% NaOH solution, fixing the volume to 1000ml, wrapping by using tin foil paper, and sterilizing in a sterilizing box for later use.
3. Antibacterial experiments
Diluting cultured strain with LB solution 10 times, and measuring OD600And (4) diluting the strain to 0.01 for later use. Taking out the 96-well plate, adding bacterial liquid and photosensitive antibacterial agent, incubating in an incubator at 37 deg.C for 1h, irradiating one group for 30min, and treating the other group in dark for 30 min; after illumination, the solution in the 96-well plate is coated in a solid culture dish and then cultured for 12 hours at 37 ℃; the culture dish was removed and the growth of the bacteria in the culture dish was observed.
Results of the experiment
In FIG. 4A, B shows the growth of bacteria in the presence or absence of light, with a light sensitive antimicrobial agent added to the vesicles. It is clear from the figure that in the presence of light, no bacteria have grown; in the absence of light, the bacteria had grown over the entire dish.
C, D in FIG. 4 shows the growth of bacteria in the absence of light, without the addition of a photosensitive antimicrobial agent to the vesicles. It can be observed from the figure that the culture dish is full of bacteria regardless of whether it is illuminated or not.
Example 3
The application of the intelligent antibacterial hydrogel in the influence of the intelligent photosensitive antibacterial agent on the mouse wound healing comprises the following operation steps:
1 materials of the experiment
1.1 Experimental reagents
Hypericin or natural photosensitive antibacterial agent extract, medical alcohol, and diluted bacteria solution
1.2 Experimental animals
Kunming mouse
2 method of experiment
2.1 mouse wound model fabrication
Taking a healthy mouse, anesthetizing the mouse by using urethane, taking clean scissors, removing the hair of the mouse, disinfecting the hair-removed part by using medical alcohol, and then manufacturing an 2 wound model with the area of about 1cm on the back of the mouse by using the disinfected scissors and tweezers.
2.2 grouping and administration
The mice are divided into an experimental group and a control group, wherein each group comprises 10 mice, the experimental group is coated with bacteria and placed with intelligent hydrogel containing photosensitive antibacterial agent at the wounds of the mice, and the control group is coated with bacteria only at the wounds without other treatment. The experiment is to irradiate the wound of the mouse for 1h, and then observe and record the healing condition of the wound of the mouse. Mice were examined histologically on wound skin on day 7 of the experiment.
2.3 histological analysis
Soaking the skin in 4% formalin for 24 hr, rinsing skin tissue, dehydrating, transparentizing, soaking in wax, embedding, making wax block slice, and slicing with slicer (thickness of 3-5 μm); drying for 2-3h in an oven, dewaxing with xylene for 5min (4 times in total), and washing off xylene; scraping magnesium oxide on the surface of the hematoxylin, and dyeing the hematoxylin; staining the dewaxed slices in hematoxylin for 5min, washing with tap water for three times, differentiating with 1% hydrochloric acid alcohol differentiation solution, soaking the slices in water for 5-10min, soaking the slices in eosin staining solution for 30s, observing the color under a microscope, prolonging the soaking time if the color is light, soaking the slices in 95% alcohol once, drying in an oven, dropping 2 drops of neutral gum, covering with a cover glass, and drying overnight.
2.4 results of the experiment
FIG. 5 is a histological section of a wound of a mouse, wherein A is a section of a normal mouse not infected with bacteria, B is an illuminated group infected with a bacterial solution and then added with a photosensitive antibacterial agent, and C is a non-illuminated group infected with a bacterial solution and then added with a photosensitive antibacterial agent. Observed under a microscope: b contains a small amount of lymphocytes, and C has a large amount of lymphocytes, so that the photosensitive antibacterial agent can play a role in sterilization under the condition of illumination.
In conclusion, the invention provides the wound dressing with detection and antibacterial effects, and the three common pathogenic bacteria, namely pseudomonas aeruginosa, escherichia coli and staphylococcus aureus, are subjected to enzymatic reaction, and the three common pathogenic bacteria are efficiently and sensitively detected in real time according to the fact that whether fluorescence is emitted and the strength of a fluorescence signal is detected. Natural photosensitive antibacterial agents such as hypericin and the like are filled into the vesicles, cytotoxin generated by pathogenic bacteria can cause the response of vesicle cracking, so that the photosensitive antibacterial agents are released from the vesicles, and the intelligent detection and treatment of the pathogenic bacteria are synchronously carried out.

Claims (4)

1. A preparation method of intelligent antibacterial hydrogel is characterized by comprising the following operation steps: 1) 73.4mg of phospholipid 1, 2-dipalmitoyl-Sn-glycero-3-phosphocholine (DPPC), 38.6mg of cholesterol and 34.6mg of 10, 12-tricosane-dienoic acid (TCDA) were weighed out and dissolved in 1mL of chloroform at a concentration of 100mmol/dm3Mixing 660 mu L of DPPC, 240 mu L of cholesterol and 300 mu L of TCDA in nitrogen flow, and then drying, removing impurities and dehydrating;
2) will contain 50mmol/dm3Mixing 10mL buffer solution of fluorescent agent with lipid, freezing for circulation, extruding the lipid mixture through a polycarbonate membrane by a vesicle extruder, and storing the vesicle at 4 ℃ for later use;
3) the size of the product is 90X 1mm3The hydrogel dressing is characterized in that 4-methyl umbelliferyl- α -D-Mannoside (MUD) is grafted on the hydrogel, an enzyme released by pathogenic bacteria can cut MUD fluorescer, a fluorophore 4-methyl umbelliferone (4-MU) is released into the hydrogel, blue light is shown under an ultraviolet lamp (lambda is 365nm), cylindrical pores with uniform intervals are carved on the prepared hydrogel dressing, and each pore has uniform diameter and depth;
4) the filling materials in the sac are the sac body, a pathogen detection fluorescent agent and chitosan, the fluorescent agent not only can detect pathogens, but also can play a role in sterilization under the condition of natural illumination, and the main antibacterial photosensitizer is natural photosensitive antibacterial agents such as hypericin and the like.
2. An application of intelligent antibacterial hydrogel in the detection of pathogenic bacteria is characterized in that,
1) enzymatic reaction in solution
For the enzymatic reaction in the solution, 50 mul of MUD solution is added into a 96-well plate filled with 50 mul of bacterial liquid, the 96-well plate is sealed by a sealing adhesive tape, and the 96-well plate is placed into a fluorescence pool to observe the fluorescence intensity;
2) enzymatic reaction of hydrogel dressing on culture dish
Grafting 50 mu L of MUD solution on the surface of the prepared hydrogel dressing, then placing the hydrogel dressing on a culture dish coated with 50 mu L of bacterial liquid, and observing the luminous intensity of the hydrogel dressing;
3) preparation of hypericin clathrate
Adding β -CD (β -cyclodextrin) 5.0g into 30% NaOH solution 10ml, stirring at room temperature to dissolve β -CD, adding EP 2.41ml into the mixed solution at 30 ℃, stirring for 24h, cooling to room temperature, desalting by a dialysis method, evaporating the solution in a dialysis bag to be viscous, adding absolute ethyl alcohol, precipitating white solid, filtering the white solid, and carrying out vacuum freeze drying to obtain β -CDP (β -cyclodextrin polymer), dissolving β -CDP 80mg and Hyp (hypericin) 10mg in a proper amount of water, fully stirring for at least 24h at room temperature, filtering the mixed solution after the reaction is finished, removing the residual Hyp to obtain a deep purple solution containing an inclusion compound, and carrying out vacuum freeze drying to obtain a deep purple product Hyp- β -CDP (hypericin inclusion compound);
4) hypericin clathrate is filled into vesicle
Uniformly preparing a plurality of round holes in the hydrogel, adding vesicles and chitosan into the holes, wherein the fillers in the vesicles are hypericin clathrate or other natural photosensitive antibacterial agents.
3. The application of the intelligent antibacterial hydrogel in an intelligent antibacterial experiment is characterized by comprising the following steps of;
1) bacterial culture
Picking bacteria from an LB flat plate, putting the bacteria into a 50ml centrifuge tube, adding 10ml of LB culture solution into the centrifuge tube, and putting the centrifuge tube into a shaker at 37 ℃ for culturing for 15 hours for later use;
2) preparation of solid Medium
Taking a 1000ml beaker, adding 500ml of distilled water, weighing 5g of beef extract, 10g of peptone, 5g of agar and 5g of sodium chloride, dissolving in water, adjusting the pH to about 7.2 by using a 10% NaOH solution, fixing the volume to 1000ml, wrapping by using tin foil paper, and sterilizing in a sterilizing box for later use;
3) antibacterial experiments
Diluting cultured strain with LB solution 10 times, and measuring OD600Diluting the strain to 0.01 for later use, taking out a 96-well plate, adding a bacterial liquid and a photosensitive antibacterial agent, incubating for 1h in an incubator at 37 ℃, and irradiating one group for 30min while keeping the other group away from light for 30 min; after illumination, the solution in the 96-well plate is coated in a solid culture dish and then cultured for 12 hours at 37 ℃; the culture dish was removed and the growth of the bacteria in the culture dish was observed.
4. The application of the intelligent antibacterial hydrogel in the influence of the intelligent photosensitive antibacterial agent on the healing of the mouse wound is characterized by comprising the following steps of;
1) experimental Material
1.1) test reagents
Hypericin or natural photosensitive antibacterial agent extract, medical alcohol, and diluted bacteria solution;
1.2) mouse of Experimental animal Kunming
2) Experimental methods
2.1) mouse wound model preparation
Anaesthetizing a healthy mouse by using urethane, removing hair of the mouse by using clean scissors, disinfecting the hair-removed part by using medical alcohol, and manufacturing an 2 wound model with the area of about 1cm on the back of the mouse by using the disinfected scissors and tweezers;
2.2) grouping and administration
Dividing the mice into an experimental group and a control group, wherein each group comprises 10 mice, the experimental group is coated with bacteria and placed with intelligent hydrogel containing photosensitive antibacterial agent at the wounds of the mice, and the control group is coated with bacteria only at the wounds without other treatment; the wound of the mouse is illuminated for 1h in the experiment, then the healing condition of the wound of the mouse is observed and recorded, and the wound skin of the mouse is subjected to histological examination on the 7 th day of the experiment;
2.3) histological analysis
Soaking the skin in 4% formalin for 24 hr, rinsing skin tissue, dehydrating, transparentizing, soaking in wax, embedding, making wax block slice, and slicing with slicer (thickness of 3-5 μm); drying for 2-3h in an oven, dewaxing with xylene for 5min (4 times in total), and washing off xylene; scraping magnesium oxide on the surface of the hematoxylin, and dyeing the hematoxylin; staining the dewaxed slices in hematoxylin for 5min, washing with tap water for three times, differentiating with 1% hydrochloric acid alcohol differentiation solution, soaking the slices in water for 5-10min, soaking the slices in eosin staining solution for 30s, observing the color under a microscope, prolonging the soaking time if the color is light, soaking the slices in 95% alcohol once, drying in an oven, dropping 2 drops of neutral gum, covering with a cover glass, and drying overnight.
CN201911074386.XA 2019-11-06 2019-11-06 Preparation method and application of intelligent antibacterial hydrogel Pending CN110743035A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911074386.XA CN110743035A (en) 2019-11-06 2019-11-06 Preparation method and application of intelligent antibacterial hydrogel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911074386.XA CN110743035A (en) 2019-11-06 2019-11-06 Preparation method and application of intelligent antibacterial hydrogel

Publications (1)

Publication Number Publication Date
CN110743035A true CN110743035A (en) 2020-02-04

Family

ID=69282363

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911074386.XA Pending CN110743035A (en) 2019-11-06 2019-11-06 Preparation method and application of intelligent antibacterial hydrogel

Country Status (1)

Country Link
CN (1) CN110743035A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112011589A (en) * 2020-08-18 2020-12-01 北京诺康达医药科技股份有限公司 Pathogenic microorganism color developing agent and preparation method and application thereof
CN113144280A (en) * 2021-03-31 2021-07-23 温州医科大学慈溪生物医药研究院 Intelligent antibacterial hydrogel and application thereof
CN115850735A (en) * 2022-12-13 2023-03-28 华南理工大学 Temperature-sensitive self-plastic stretchable hyaluronic acid/beta-cyclodextrin hydrogel and preparation method and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7521796A (en) * 1995-10-25 1997-05-15 Eoe, Inc. Microporous pathogen-killing composition
CN102573800A (en) * 2009-08-10 2012-07-11 台湾微脂体股份有限公司 Ophthalmic drug delivery system containing phospholipid and cholesterol
CN107469140A (en) * 2017-08-14 2017-12-15 高鼎精细化工(昆山)有限公司 A kind of photodynamics antiseptic dressing for having antibacterial functions, preparation method and application
CN107823695A (en) * 2017-09-19 2018-03-23 华东理工大学 A kind of intelligent antiseptic dressing and preparation method thereof
CN109453408A (en) * 2018-11-16 2019-03-12 江南大学 Antibacterial wound dressing and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7521796A (en) * 1995-10-25 1997-05-15 Eoe, Inc. Microporous pathogen-killing composition
CN102573800A (en) * 2009-08-10 2012-07-11 台湾微脂体股份有限公司 Ophthalmic drug delivery system containing phospholipid and cholesterol
CN107469140A (en) * 2017-08-14 2017-12-15 高鼎精细化工(昆山)有限公司 A kind of photodynamics antiseptic dressing for having antibacterial functions, preparation method and application
CN107823695A (en) * 2017-09-19 2018-03-23 华东理工大学 A kind of intelligent antiseptic dressing and preparation method thereof
CN109453408A (en) * 2018-11-16 2019-03-12 江南大学 Antibacterial wound dressing and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MIR-MORTEZA, ET AL: "Autonomously Sensing Hydrogels for the Rapid and Selective Detection of Pathogenic Bacteria", 《MACROMOLECULAR RAPID COMMUNICATIONS》 *
肖冬梅等: "金丝桃素对铜绿假单胞菌的体外光动力杀菌研究", 《广东大学学报(自然科学报)》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112011589A (en) * 2020-08-18 2020-12-01 北京诺康达医药科技股份有限公司 Pathogenic microorganism color developing agent and preparation method and application thereof
CN112011589B (en) * 2020-08-18 2022-07-01 北京诺康达医药科技股份有限公司 Pathogenic microorganism color developing agent and preparation method and application thereof
CN113144280A (en) * 2021-03-31 2021-07-23 温州医科大学慈溪生物医药研究院 Intelligent antibacterial hydrogel and application thereof
CN115850735A (en) * 2022-12-13 2023-03-28 华南理工大学 Temperature-sensitive self-plastic stretchable hyaluronic acid/beta-cyclodextrin hydrogel and preparation method and application thereof

Similar Documents

Publication Publication Date Title
Liu et al. Direct synthesis of photosensitizable bacterial cellulose as engineered living material for skin wound repair
Pirnazar et al. Bacteriostatic effects of hyaluronic acid
EP2646566B1 (en) A composition for detecting biofilms on viable tissues
CN105908363B (en) A kind of electrostatic spraying laminated film and preparation method and application
Tumin et al. Antibacterial activity of local Malaysian honey
Shinde et al. Biofilm formation by Candida albicans on various prosthetic materials and its fluconazole sensitivity: a kinetic study
Wang et al. Wound therapy via a photo-responsively antibacterial nano-graphene quantum dots conjugate
Coquet et al. Resistance of artificial biofilms of Pseudomonas aeruginosa to imipenem and tobramycin.
CN110743035A (en) Preparation method and application of intelligent antibacterial hydrogel
Poor et al. Control of multi-drug-resistant pathogens with non-thermal-plasma-treated alginate wound dressing
Valente et al. The increased killing of biofilms in vitro by combining topical silver dressings with topical negative pressure in chronic wounds
Xiong et al. Derma-like antibacterial polysaccharide gel dressings for wound care
Fei et al. Biomimetic cerium oxide loaded gelatin PCL nanosystems for wound dressing on cutaneous care management of multidrug-resistant bacterial wound healing
Huang et al. Octenidine dihydrochloride treatment of a meticillin-resistant Staphylococcus aureus biofilm-infected mouse wound
Lorenz et al. Development of In Vitro and Ex Vivo Biofilm Models for the Assessment of Antibacterial Fibrous Electrospun Wound Dressings
Wang et al. Continuous and controllable electro-fabrication of antimicrobial copper-alginate dressing for infected wounds treatment
Paleczny et al. Comparison of antibiofilm activity of low-concentrated hypochlorites vs polyhexanide-containing antiseptic
Al-Dujaily et al. Evaluation of Antibacterial and antibiofilm activity of biogenic silver nanoparticles and gentamicin against Staphylococcus aureus isolated from caprine mastitis
Parmar et al. Antimicrobial Study of Chitosan-Based Crosslinked Hydrogel Against Staphylococcus aureus, Porphyromonas gingivalis, Pseudomonas aeruginosa, and Streptococcus mutans
Ghada et al. Golden apple snail eggs extract: biosynthesis of nanoparticles and its antibacterial effect
Liu et al. Dual-acting antibacterial porous chitosan film embedded with a photosensitizer
US20210178010A1 (en) Bioactive wound dressing
Falciglia et al. In vitro antimicrobial activity evaluation of a novel Fitostimoline® plus spray formulation
TWI736995B (en) Novel small molecule compounds and their uses
CN111494304B (en) Polysaccharide-based hybrid hydrogel and construction method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200204

WD01 Invention patent application deemed withdrawn after publication